Balakrishnan M - Search Results

1

Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally-Derived Anthropometric Measures.

Balakrishnan M, El-Serag HB, Nguyen T, Hilal J, Kanwal F, Thrift AP. Balakrishnan M, et al. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1965-1967. doi: 10.1016/j.cgh.2017.06.030. Epub 2017 Jun 20. Clin Gastroenterol Hepatol. 2017. PMID: 28642206 Free PMC article. No abstract available.

2

Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey.

Balakrishnan M, Kanwal F, El-Serag HB, Thrift AP. Balakrishnan M, et al. Clin Gastroenterol Hepatol. 2017 Feb;15(2):310-312. doi: 10.1016/j.cgh.2016.09.149. Epub 2016 Oct 3. Clin Gastroenterol Hepatol. 2017. PMID: 27712983 Free PMC article. No abstract available.

3

Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.

Balakrishnan M, El-Serag HB, Kanwal F, Thrift AP. Balakrishnan M, et al. Dig Dis Sci. 2017 Feb;62(2):526-533. doi: 10.1007/s10620-016-4401-1. Epub 2016 Dec 19. Dig Dis Sci. 2017. PMID: 27995401

4

Hepatitis C and Risk of Nonhepatic Malignancies.

Balakrishnan M, Glover MT, Kanwal F. Balakrishnan M, et al. Clin Liver Dis. 2017 Aug;21(3):543-554. doi: 10.1016/j.cld.2017.03.009. Epub 2017 Apr 22. Clin Liver Dis. 2017. PMID: 28689592 Review.

5

Editorial: NAFLD-related hepatocellular carcinoma - increasing or not? With or without cirrhosis?

Balakrishnan M, El-Serag HB. Balakrishnan M, et al. Aliment Pharmacol Ther. 2018 Feb;47(3):437-438. doi: 10.1111/apt.14464. Aliment Pharmacol Ther. 2018. PMID: 29314126 Free PMC article. No abstract available.

6

Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis.

Wang Z, Graham DY, Khan A, Balakrishnan M, Abrams HR, El-Serag HB, Thrift AP. Wang Z, et al. Among authors: balakrishnan m. Int J Epidemiol. 2018 Jun 1;47(3):966-975. doi: 10.1093/ije/dyy055. Int J Epidemiol. 2018. PMID: 29672681 Free PMC article.

7

Treatment of Dyslipidemia in Common Liver Diseases.

Speliotes EK, Balakrishnan M, Friedman LS, Corey KE. Speliotes EK, et al. Among authors: balakrishnan m. Clin Gastroenterol Hepatol. 2018 Aug;16(8):1189-1196. doi: 10.1016/j.cgh.2018.04.023. Epub 2018 Apr 21. Clin Gastroenterol Hepatol. 2018. PMID: 29684459 Free PMC article. Review. No abstract available.

8

PROs of Patient-reported Outcomes for Nonalcoholic Fatty Liver Disease and Effects on Treatment for Nonalcoholic Steatohepatitis.

Balakrishnan M, Loomba R. Balakrishnan M, et al. Clin Gastroenterol Hepatol. 2019 Sep;17(10):1950-1953. doi: 10.1016/j.cgh.2019.04.018. Epub 2019 Apr 10. Clin Gastroenterol Hepatol. 2019. PMID: 30981002 No abstract available.

9

The HCV Treatment Cascade: Race Is a Factor to Consider.

Balakrishnan M, Kanwal F. Balakrishnan M, et al. J Gen Intern Med. 2019 Oct;34(10):1949-1951. doi: 10.1007/s11606-019-04962-3. J Gen Intern Med. 2019. PMID: 31342332 Free PMC article. No abstract available.

10

The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLD.

Balakrishnan M, Loomba R. Balakrishnan M, et al. J Clin Gastroenterol. 2020 Feb;54(2):107-113. doi: 10.1097/MCG.0000000000001284. J Clin Gastroenterol. 2020. PMID: 31789757 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page